-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Kmd6gqwi5c7GXm4x5nBxHQL/tdlMzs1o9kwFllKlgsC5SgSftuMcZkr1gydJU5vv vM1IQdabDv3zQHT60+bwUA== 0001104659-03-021185.txt : 20030919 0001104659-03-021185.hdr.sgml : 20030919 20030919172503 ACCESSION NUMBER: 0001104659-03-021185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030917 FILED AS OF DATE: 20030919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AVENTIS INC CENTRAL INDEX KEY: 0000217028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21291 FILM NUMBER: 03903184 BUSINESS ADDRESS: STREET 1: 500 ARCOLA RD STREET 2: P O BOX 1200 M/S 5B14 CITY: COLLEGEVILLE STATE: PA ZIP: 19426-0107 BUSINESS PHONE: 6104548000 FORMER NAME: FORMER CONFORMED NAME: RHONE POULENC RORER INC DATE OF NAME CHANGE: 19920703 FORMER NAME: FORMER CONFORMED NAME: RORER GROUP INC DATE OF NAME CHANGE: 19900731 FORMER NAME: FORMER CONFORMED NAME: RORER AMCHEM INC DATE OF NAME CHANGE: 19770604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTROGEN THERAPEUTICS INC CENTRAL INDEX KEY: 0001018710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 742704230 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 CONGRESS AVE STREET 2: SUITE 1850 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 5127089310 MAIL ADDRESS: STREET 1: 301 CONGRESS AVE STREET 2: SUITE 1850 CITY: AUSTIN STATE: TX ZIP: 78701 4 1 a4.xml 4 X0201 4 2003-09-17 0 0001018710 INTROGEN THERAPEUTICS INC INGN 0000217028 AVENTIS INC 300 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 0 0 1 0 Common 2003-09-17 4 S 0 700000 10.18 D 0 I See Footnote Common 2003-09-18 4 S 0 14600 10.75 D 2770093 I See Footnote Owned directly by Aventis Holdings Inc, and beneficially owned by Aventis Inc. The Number of shares set forth under this column 5 on the Company's Form 4 Filed on September 12, 2003 was incorrectly reported as 3,560,293 instead of 3,520,293 Gerald P.Belle, President 2003-09-19 EX-99.1 3 ex-99d1.htm EX-99.1

Exhibit 99.1

Joint Filer Information

 

Name:

 

Aventis Holdings Inc.

 

 

 

Address:

 

3711 Kennett Pike, Suite 200

 

 

Greenville, Delaware 19807

 

 

 

Designated Filer:

 

Aventis Inc.

 

 

 

Issuer:

 

Introgen Therapeutics Inc.

 

 

 

Nature of Interest:

 

Direct (1)

 

 

 

Date of Event

 

 

Requiring Statement:

 

September 17-18, 2003

 

 

 

Signature:

 

 

/s/ Joseph M. Palladino

 

 -----END PRIVACY-ENHANCED MESSAGE-----